British American Tobacco has ceased its involvement in the commercialisation of the medically licensed Voke nicotine inhaler.
Written by Freddie Dawson || 11th January 2017 || Business briefing |
Regulatory and market intelligence for the e-cigarette sector
Start your FREE 7-day trial now
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions
15% off during April only
By submitting your data you agree to our Terms and Conditions
